Correction to: Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer's disease.
Boza-Serrano A, Ruiz R, Sanchez-Varo R, García-Revilla J, Yang Y, Jimenez-Ferrer I, Paulus A, Wennström M, Vilalta A, Allendorf D, Davila JC, Stegmayr J, Jiménez S, Roca-Ceballos MA, Navarro-Garrido V, Swanberg M, Hsieh CL, Real LM, Englund E, Linse S, Leffler H, Nilsson UJ, Brown GC, Gutierrez A, Vitorica J, Venero JL, Deierborg T.
Boza-Serrano A, et al. Among authors: vitorica j.
Acta Neuropathol. 2023 Apr;145(4):509-510. doi: 10.1007/s00401-023-02549-1.
Acta Neuropathol. 2023.
PMID: 36790609
Free PMC article.
No abstract available.